The use of pretransplant erythropoietin to normalize hemoglobin levels has no deleterious effects on renal transplantation outcome

Transplantation

Volumn 71, Issue 1, 2001, Pages 79-82

  Linde, Torbjörn ^a   Ekberg, Henrik ^b   Forslund, Terje ^c   Furuland, Hans ^a   Holdaas, Hallvard ^d   Nyberg, Gudrun ^e   Tydén, Gunnar ^f   Wahlberg, Jan ^a   Danielson, Bo G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCANDINAVIA; TREATMENT OUTCOME;

EID: 0035862985     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200101150-00013     Document Type: Article

References (19)

1. The pathophysiology of ischaemic acute renal failure. A new hypothesis about the initiation phase
2. The effect of type of preservation solution and hemodilution of the recipient on postischemic erythrocyte trapping in kidney grafts. An experimental study in the rat
3. Reversal of acute renal failure using hemodilution with hydroxyethyl starch
4. Red cell trapping after ischemia and long-term kidney damage. Influence of hematocrit
5. Influence of the pretransplant hematocrit level on early graft function in primary cadaveric renal transplantation
6. Effect of pretransplant erythropoietin therapy on renal allograft outcome
7. Renal transplantation: Results in hemodialysis patients previously treated with recombinant human erythropoietin
8. Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. A European multicentre study in 142 patients to define dose regimen and safety profile
9. Outcome of renal transplantation in patients treated with erythropoietin
10. Target haematocrit during erythropoietin therapy
11. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
12. Effect of rHuEpo therapy in dialysis patients on endogenous erythropoietin synthesis after renal transplantation
13. Treatment of chronic renal failure anemia by recombinant erythropoietin and polycythemia following kidney transplantation
14. Immunomodulatory action of human recombinant erythropoietin in man
15. Anemia of uremia is associated with reduced in vitro cytokine secretion: Immunopotentiating activity of red blood cells
16. Early thrombosis in kidney grafted into patient treated with erythropoietin
17. Haemodilution in renal transplantation in patients on erythropoietin
18. Effects of Epoetin alfa on hemostasis in chronic renal failure
19. Primary renal graft thrombosis